DriverMap™ Targeted RNA Sequencing of Blood Finds Gene Signatures Linked to Labor

A recent article demonstrates the unique suitability of the DriverMap Expression Profiling Assay for blood biomarker analysis. In Scientific Reports, Tarca, et al. reported that DriverMap Targeted RNA sequencing identified more potential biomarkers associated with spontaneous labor than either standard Illumina RNA-seq or Affymetrix Transcriptome Arrays.

Blood carries markers for changes related to disease progression, tumorigenesis, drug treatments, diet, or other physiological responses. The trick is to detect the specific changes of interest. Broad screening methods for proteins and other biological intermediates are limited, but RNA can be assayed rapidly and robustly in a standardized highly parallel manner to identify suitable clinical biomarkers. DriverMap Genome-Wide Expression Profiling System provides a convenient targeted RNA sequencing approach that is particularly suited for this purpose.

DriverMap Targeted RNA sequencing specifically amplifies a short representative sequence for each gene transcript. As a result, sequencing is significantly simplified and the resulting data from NGS can be directly correlated with expression.

Further, the large number of rearranged beta-globin sequences in blood samples produce high levels of background and complicate bioinformatic analysis. Typically, beta-globin depletion of blood samples is required which, in addition to being inconvenient, can compromise the quantitative reliability of the analysis. With the DriverMap Assay, however, targeted primers for each gene eschew interference from background ribosomal or beta-globin RNA. Total RNA samples can be used directly so sample preparation is simpler and the resulting data cleaner.

In the recent study by Tarca, et al (Scientific Reports, 2019), blood samples extracted from 32 pregnant women were analyzed by all three methods. The researchers found that, “Although over three times more total aligned reads per sample were obtained for RNA-Seq than for DriverMap, the number of aligned reads per sample for protein coding gene content was about three times less for RNA-Seq, and it varied more across samples compared to DriverMap.” Further, they discovered that, “DriverMap is especially suitable to track cell type specific signature as it leads to strong associations and expression summaries that correlate better with qRT-PCR results.”

Based on the transcriptome profiling data, the researchers were able to identify a set of T-cell-specific marker genes show, for the first time, a significant increase in these with the onset of labor (as shown in figure). This finding is consistent with other studies suggesting a general role for T cells in the labor process.

DriverMap-RNASeq-and-microarray-performance-comparison



Also in Cellecta Blog & News

Gene Expression Profiling of Single-Cell Samples: DriverMap Targeted Expression Profiling vs SMART Technology

Single-cell expression analysis provides insights about gene expression and cell heterogeneity at the single-cell level. It enables the elucidation of intracellular gene regulatory networks and intracellular pathways that would otherwise be masked in bulk analysis (Massaia et al., 2018). The DriverMap™ Targeted Gene Expression Profiling (TXP) assay combines highly multiplexed RT-PCR amplification with the depth and precision of Next-Generation Sequencing (NGS) to quantitatively measure gene expression of up to 19,000 target genes in a single assay–even down to the single-cell level.
Read More
Comparing DNA vs. RNA Samples for Immune Repertoire Profiling

Adaptive immunity relies on B and T cells that recognize foreign antigens via hypervariable B cell and T cell receptors (BCRs and TCRs). Diversity among B cell and T cell receptors is primarily produced by V(D)J recombination, which involves the shuffling and joining of the variable (V), diversity (D), joining (J), and constant region (C) gene segments. This results in a diverse repertoire called the adaptive immune repertoire (AIR) that comprises multiple individual clonotypes (sequence) for particular receptor chains.
Read More
Inducible Cas9 Expression in a Single Lentiviral Vector

Introducing Inducible Cas9 Expression in a Single Lentiviral Vector to make cells capable of high Cas9 expression for a limited time during which CRISPR-mediated targeted rearrangements can occur, and then shut off Cas9 expression for downstream assays with the modified cells.
Read More